SCION NEUROSTIM, LLC

DURHAM, NC · Founded 2021 · Medtech · Private

Non-invasive brainstem stimulation device for treating Parkinson's disease dementia

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
DURHAM, NC
Founded
2021
Latest Form D
$10M, Oct 2023
Total capital
$11M
Federal grants
$994K
2 awards · 2023–2024
Rank in peer group#464 of 477
Private capital raised
$10M
1 Form D · last Oct 2023
36 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
15 pending · first 2017
Rank in peer group#15 of 477

Capital timeline

20232024FEDERAL ↑EQUITY ↓Cumulative $11M$667K$328K1st Form D$10M
20232024FEDERAL ↑EQUITY ↓Cumulative $11M$667K$328K1st Form D$10M

Latest events

  • Federal grantHealth and Human S · Phase I · Simple, Home-use, neurostimulAtion tReatment for Parkinson's disease dEmeNtia (SHARPEN)$328K
  • Private capital raisedForm D · SEC · 1st filing$10M
  • Federal grantHealth and Human S · Phase I · Simple, Home-use, neurostimulAtion tReatment for Parkinson's disease dEmeNtia (SHARPEN)$667K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

3months

from SCION NEUROSTIM, LLC’s first federal award to its first private round.

First federal award · Jul 2023
Health and Human S · $667K
First Form D · Oct 2023
$10M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#15 · top 3%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Lesco L RogersResearcherDirectorLinked by 8 patents
  • Robert L BlackResearcherDirectorLinked by 4 patents
  • Lanty L SmithResearcherExecutive Officer, Director, PromoterLinked by 3 patents
  • Steven L BischoffDirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 30
Show all 30 patent records
  • REVBIO, INC.Similar federal contract value in Medtech · null in contracts
  • ENDOMEDIX, INC.Similar federal contract value in Medtech · null in contracts
  • PHAST CORPSimilar federal contract value in Medtech · null in contracts
  • CONTRALINE, INC.Similar federal contract value in Medtech · null in contracts
  • FAUXSEE INNOVATIONS LLCSimilar federal contract value in Medtech · null in contracts
  • CELL IDX, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .